explore -WSS

explore

author：explore 2025-09-29 17:02:22 - browse：27495

An orange Flovent inhaler on a white background. -- health coverage from STAT — Adobe

As of Jan. 1, thousands of asthma patients in the U.S. will no longer be able to get refills for Flovent — one of the most popular inhalers in the U.S. for nearly 30 years.

Flovent’s manufacturer, GSK, has discontinued both versions of the product — Flovent HFA, an inhalation aerosol, and Flovent Diskus, an inhalation powder — and replaced each with what is known as an “authorized generic,” essentially the same product sold under a private label. Prasco, a U.S. drugmaker specializing in authorized generics, will distribute the new inhaler, sold as fluticasone.

The timing of the change is telling: Flovent’s price rose nearly 50% since 2014, according to GoodRx, leaving the drug vulnerable to the new Medicaid penalties going into effect as of this year for medications with price increases that outpace inflation. By discontinuing the brand-name inhaler but continuing to earn money from the authorized generic, GSK will be able to avoid paying a penalty.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Physicians and social media: If you see something, say something?

WSS

ACA's risk program benefits Blue Cross Blue Shield insurers

AstraZeneca to buy developer of next

ACA's risk program benefits Blue Cross Blue Shield insurers

Teachers share how revamped forgiveness program helped with their student loans

Colonoscopy prep: Liquid

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

Wikipedia

explore

hotspot

New air purifier tech could be key to improving indoor air quality

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

In age of alternative facts, a scholarly course on calling out crap

SCOTUS questions limit to govt efforts to fight misinformation

Jerome Adams on the need for new antivirals for Covid

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

Medical records are filled with copy

Biden declares emergency in flood

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Pandemic and All Hazards Preparedness Act needs lean update

explore

Swim instructor mom warns parents not to buy blue swimsuits for kids

The aspartame in Diet Coke probably isn’t giving you cancer

Wisconsin governor employs partial veto to fund schools for 4 centuries

UnitedHealth increases loan offers after Change Healthcare outage

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

Stop the failed accountable care organization experiment

entertainment

Wikipedia

leisure time

focus